Due to the limited amount of 1 and 2, only compounds 3–8 were screened for their inhibitory activity on Cav3.1 low voltage-gated calcium channel (LVGCC), an important therapeutic target for cardiovascular disease [23]. This evidence concerns the gene CACNA1G and cardiovascular disorder.